Clinical and Immunological Evaluation of Children with Allergic Disease

儿童过敏性疾病的临床和免疫学评估

基本信息

项目摘要

The NIH Pediatric Allergy Clinic has provided residents in the NIAID Allergy and Immunology Clinical Fellowship Program with medical training and continuity clinic experience in pediatric allergic diseases including asthma, allergic rhinitis, food allergy, atopic dermatitis and urticaria. During the past fiscal year, patient care visits exceeded 350, with a total accrual of 260 new patients. The NIH Pediatric Allergy Clinic also provides clinical resources for the study of children with allergic inflammatory disorders. In addition to standard diagnostic testing for allergic diseases, which includes skin prick testing, radioallergosorbent (RAST) testing, patch testing and pulmonary function testing, the clinic has integrated other modalities in the evaluation of children with allergic diseases. To evaluate lung function we have emplotyed impulse oscillometry, a non-invasive, non-effort dependant technique that measures lung resistance and elasticity. This is being used in conjunction with standard pulmonary function testing in older children and by itself in infants as young as two years old. A manuscript reviewing the clinical application of impulse oscillometry in pediatric patients with asthma is being prepared for publication. Through consultation with the NHLBI pulmonology service, exercise challenge pulmonary function testing has been performed. In conjunction with other investigators in the LAD, expired breath condensate and exhaled nitric oxide measurements have been obtained for diagnostic and research purposes. Research blood has been collected for laboratory studies to measure markers of allergic diseases, develop approaches to culture mast cells from blood, and determine cytokine and signaling profiles. In particular, serum tryptase levels were measured in 44 non-atopic and 153 atopic clinic patients. Median and 95% prediction intervals of tryptase levels for non-atopics were 3.44, 0.64-6.77 and 3.56, 0.98-10.80 for atopics. This study, recently published in the Journal of Allergy and Clinical Immunology (9 August 2009 on-line) establishes normative serum reference tryptase values in atopic and non-atopic children. Among atopics, a statistically significant association with tryptase was found for gender and race but not for ethnicity, total IgE levels, weight/weight percentile or eczema status. Patient documentation for communication with referring physicians and for longitudinal analysis is entered into CRIMSON, the NIAID database system.
NIH儿科过敏诊所为NIAID过敏和免疫学临床奖学金计划的居民提供儿科过敏性疾病(包括哮喘、过敏性鼻炎、食物过敏、特应性皮炎和荨麻疹)的医疗培训和连续性诊所经验。在上一个财政年度,病人护理访问超过350次,共增加260名新病人。美国国立卫生研究院小儿过敏症诊所也为儿童过敏性炎症性疾病的研究提供临床资源。 除了过敏性疾病的标准诊断测试(包括皮肤点刺测试、放射性过敏吸附剂(RAST)测试、斑贴测试和肺功能测试)外,该诊所还整合了其他模式来评估患有过敏性疾病的儿童。 为了评估肺功能,我们采用了脉冲阻力测定法,这是一种测量肺阻力和弹性的非侵入性、非努力依赖性技术。 这是与标准肺功能测试结合使用,在年龄较大的儿童和本身在婴儿为两岁。一篇综述脉冲多普勒超声心动图在儿童哮喘患者中临床应用的论文正在准备发表。 通过咨询NHLBI肺病服务,进行了运动挑战肺功能测试。 与LAD的其他研究人员一起,已获得呼气冷凝液和呼出一氧化氮测量值,用于诊断和研究目的。 研究血液已被收集用于实验室研究,以测量过敏性疾病的标志物,开发从血液中培养肥大细胞的方法,并确定细胞因子和信号传导谱。特别是,血清类胰蛋白酶水平测定44非特应性和153特应性临床患者。类胰蛋白酶水平的中位数和95%预测区间为3.44,0.64-6.77和3.56,0.98-10.80的特应性。 这项研究最近发表在《变态反应和临床免疫学杂志》(2009年8月9日在线)上,建立了特应性和非特应性儿童的标准血清参考类胰蛋白酶值。在特应性疾病中,性别和种族与类胰蛋白酶有统计学显著相关性,但种族、总IgE水平、体重/体重百分位数或湿疹状态与类胰蛋白酶无统计学显著相关性。 将用于与转诊医生沟通和纵向分析的患者文档输入NIAID数据库系统CRIMSON。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dean D Metcalfe其他文献

Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis
  • DOI:
    10.1016/s0091-6749(02)81601-3
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Knut Brockow;Cem Akin;Mary M Huber;Dean D Metcalfe
  • 通讯作者:
    Dean D Metcalfe
Comparison of FceRI and FcγRI-dependent signaling pathways in human mast cells
  • DOI:
    10.1016/s0091-6749(02)82259-x
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Christine Tkaczyk;Yoshimishi Okayama;Dean D Metcalfe;Alasdair M Gilfillan
  • 通讯作者:
    Alasdair M Gilfillan
Serum tryptase levels combined with flow cytometric analysis of bone marrow aspirate mast cells differentiate systemic mastocytosis from idiopathic syndromes
  • DOI:
    10.1016/s0091-6749(02)81675-x
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Cem Akin;Arnold S Kirshenbaum;Dean D Metcalfe
  • 通讯作者:
    Dean D Metcalfe
Direct determination of allergen specific T cell cytokine responses during immunotherapy
  • DOI:
    10.1016/s0091-6749(02)82225-4
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    L Brigida Cayosa Hunter;Varatda Plainetr;Barbara Foster;Mary M Huber;Dean D Metcalfe;Calman Prussin
  • 通讯作者:
    Calman Prussin

Dean D Metcalfe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dean D Metcalfe', 18)}}的其他基金

REGULATION OF CYTOKINE GENE EXPRESSION IN MAST CELLS
肥大细胞中细胞因子基因表达的调节
  • 批准号:
    6098983
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Developmental Immunotherapeutics for Allergic Diseases and Asthma
过敏性疾病和哮喘的发育免疫治疗
  • 批准号:
    6099081
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Fc Receptors in Mast Cell Signaling and Function
肥大细胞信号传导和功能中的 Fc 受体
  • 批准号:
    6431716
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
  • 批准号:
    7964210
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Activation of Mast Cells in Disease States: Pharmacological Modification
疾病状态下肥大细胞的激活:药理学修饰
  • 批准号:
    7964545
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Pathogenesis of Physical Urticaria Syndromes
物理性荨麻疹综合征的发病机制
  • 批准号:
    8946474
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Pediatric Inflammatory Diseases of the Respiratory Tract: Asthma
小儿呼吸道炎症疾病:哮喘
  • 批准号:
    7732632
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Molecular Biology Of Mast Cell Growth And Differentiation
肥大细胞生长和分化的分子生物学
  • 批准号:
    7732464
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
  • 批准号:
    10014014
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:
Pathogenesis and Treatment of Anaphylaxis
过敏反应的发病机制和治疗
  • 批准号:
    10014172
  • 财政年份:
  • 资助金额:
    $ 31.67万
  • 项目类别:

相似海外基金

Study on the Effects of Activation-induced cell death of ILC2s in Patients with Allergic Rhinitis
ILC2s激活诱导细胞死亡对变应性鼻炎患者影响的研究
  • 批准号:
    23K08954
  • 财政年份:
    2023
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New mechanisms of sublingual immunotherapy for the treatment of allergic rhinitis
舌下免疫治疗治疗变应性鼻炎的新机制
  • 批准号:
    22H03233
  • 财政年份:
    2022
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Testing the effectiveness of the biological drug, Tezepelumab, in patients with coexisting allergic rhinitis and allergic asthma
测试生物药物 Tezepelumab 对同时患有过敏性鼻炎和过敏性哮喘的患者的有效性
  • 批准号:
    490921
  • 财政年份:
    2022
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Studentship Programs
The analysis of T follicular helper and regulatory cells of patients with atopic asthma comorbid with allergic rhinitis by treated with HDM-SLIT
HDM-SLIT治疗特应性哮喘合并变应性鼻炎患者滤泡辅助T及调节细胞分析
  • 批准号:
    21K08441
  • 财政年份:
    2021
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of Neuromedin U in the pathogenesis of allergic rhinitis and analysis for innovative drug discovery.
Neuromedin U 参与过敏性鼻炎的发病机制以及创新药物发现的分析。
  • 批准号:
    20K09720
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of clock genes and associated pathologies in the regulation of allergic rhinitis condition via the activation of Sirtuin1 signalling pathway.
时钟基因和相关病理通过激活 Sirtuin1 信号通路调节过敏性鼻炎病情的机制。
  • 批准号:
    20K18301
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effect of IL-33 Gene Expression suppression on allergic rhinitis
IL-33基因表达抑制对变应性鼻炎的影响
  • 批准号:
    20K09693
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Treatment of allergic rhinitis with intranasal NB-UVB irradiation
鼻内NB-UVB照射治疗过敏性鼻炎
  • 批准号:
    20K18254
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the Effects of Aging Changes on the Pathophysiology of Allergic Rhinitis
阐明衰老变化对过敏性鼻炎病理生理学的影响
  • 批准号:
    20K22995
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Novel diagnostic and preventive methods for allergic rhinitis using epigenetic analysis of nasal epithelial cells
利用鼻上皮细胞表观遗传学分析诊断和预防过敏性鼻炎的新方法
  • 批准号:
    20K18275
  • 财政年份:
    2020
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了